Your browser doesn't support javascript.
loading
The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study.
Bartlett, Sofia R; Wong, Stanley; Yu, Amanda; Pearce, Margo; MacIsaac, Julia; Nouch, Susan; Adu, Prince; Wilton, James; Samji, Hasina; Clementi, Emilia; Velasquez, Hector; Jeong, Dahn; Binka, Mawuena; Alvarez, Maria; Wong, Jason; Buxton, Jane; Krajden, Mel; Janjua, Naveed Z.
Afiliação
  • Bartlett SR; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • Wong S; Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Yu A; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • Pearce M; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • MacIsaac J; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • Nouch S; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Adu P; Division of Addiction Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Wilton J; Department of Family and Community Practice, Vancouver Coastal Health, Vancouver, BC, Canada.
  • Samji H; Department of Family Practice, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Clementi E; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • Velasquez H; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Jeong D; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • Binka M; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • Alvarez M; Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada.
  • Wong J; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • Buxton J; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Krajden M; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
  • Janjua NZ; British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Clin Infect Dis ; 74(4): 575-583, 2022 03 01.
Article em En | MEDLINE | ID: mdl-34125883
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abuso de Substâncias por Via Intravenosa / Hepatite C / Hepatite C Crônica Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abuso de Substâncias por Via Intravenosa / Hepatite C / Hepatite C Crônica Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article